Codeine Linctus Now Prescription-Only
The MHRA has reclassified codeine linctus (codeine oral solutions) from a general sales list (GSL) medicine to a prescription-only medicine (POM). This change follows a public consultation and reflects updated safety considerations for this commonly used cough suppressant.
What You Need to Know
- Codeine linctus can no longer be supplied over-the-counter without a prescription
- The reclassification applies to all codeine oral solution formulations
- This change aligns with existing restrictions on codeine-containing products and aims to improve safety monitoring
- Healthcare professionals should be aware of this change when managing patients with cough or advising on alternatives
Affected Medications
- Codeine linctus (all strengths and formulations)
- Codeine oral solutions
Recommended Actions
For prescribers: Ensure you are aware of this reclassification when considering codeine for cough management. Consider alternative treatments where appropriate, particularly in vulnerable populations.
For pharmacy and dispensing staff: Update your systems to reflect POM status. Patients requesting codeine linctus over-the-counter should be directed to their GP for a prescription if clinically appropriate.
For all responders: Be aware that codeine linctus is no longer available as a GSL product and will require a prescription in future patient encounters.
Further Information
For the full MHRA alert and detailed guidance, visit the MHRA Drug Safety Update.